Skip to main content

Table 1 Patients’ characteristics

From: Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study

Characteristic

Patients (n = 25)

Age (years), median (range)

66 (51–80)

Tumor size (mm), median (range)

28 (12–40)

Sex, n (%)

 Male

16 (64.0)

 Female

9 (36.0)

Primary tumor location, n (%)

 Head/neck

18 (72.0)

 Body

6 (24.0)

 Tail

1 (4.0)

NCCN resectability, n (%)

 Resectable

17 (68.0)

 Borderline resectable

8 (32.0)

  BR-PV

6 (24.0)

  BR-A

2 (8.0)

Completion of NACRT, n (%)

23 (92.0)

Completion of RT, n (%)

25 (100.0)

Completion of CT, n (%)

23 (92.0)

Resection rate, n (%)

17 (68.0)

Reason for protocol failure, n (%)

 Cholangitis

1 (4.0)

 Neutropenia

1 (4.0)

  1. Abbreviations: CT chemotherapy, NACRT neoadjuvant chemoradiotherapy, NCCN National Comprehensive Cancer Network, BR-PV borderline resectable-portal vein, BR-A borderline resectable-artery, RT radiotherapy